ResMed

NYS:RMD

Medical Specialties

Market Cap

$14.58bn

LARGE cap

Share Price ↑

$102.00 (0.27%)

YTD Return ↓

-8.6274%

since start of 2019

P/E Ratio

—

RMD chart by TradingView

Source: FactSet financial data and analytics.

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data Privacy
Consumer Health
Employee Satisfaction
Workplace Safety
Corp Gov
Ethical Practices
Conflict Materials
Forced Labor
Gender Diversity

Legend

About

Medical Specialties Founded 1989

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

website

Source: FactSet Research Systems

Headquarters

9001 Spectrum Center Boulevard

San Diego, CA 92123

1.858.836.5000

Executives

Name	Title	Gender
David Pendarvis	Secretary & Chief Administrative Officer	Male
Brett A. Sandercock	Chief Financial Officer	Male
Rob Douglas, MBA	President & Chief Operating Officer	Male
Mick Farrell, MBA	Chief Executive Officer & Director	Male
Peter C. Farrell, PhD,DSc	Non-Executive Chairman	Male
Carlos M. Nunez, MD	Chief Medical Officer	Male
Agnes Lee, MBA	Senior Director-Investor Relations	Female
Frank Lacagnina	Chief Information Officer	Male
Richie McHale	Chief Human Resources Officer	Male

Mindful Investing Summary

Legend

Carbon Footprint 3 N/A

ResMed is an average performer among its competitors for its carbon footprint. A company’s performance in this category is based on its success in implementing energy efficiency measures. Investments in energy efficient technology, green building and sourcing of renewable energy can all lead to cost savings and reduce the company’s contribution to climate change.
Pollution Prevention 2 N/A

ResMed performs poorly on this issue. Companies are evaluated on pollution prevention by the levels of waste (including hazardous waste) they produce and release into the environment, and can be affected by whether they develop products that can reduce exposure to pollution.
Water Conservation 3 N/A

ResMed is an average performer among its peers in this category. A company’s score in this category depends on its measures to minimize water usage and impacts on stressed or drought-prone water resources.
Data & Privacy Protection — N/A

ResMed among its peers and competitors for data privacy and protection. Companies today digitally manage vast amounts of personal information about their clients. A company’s score on this issue is based on the systems, products and procedures it has in place to minimize the risk for data and privacy breaches.
Consumer Health, Wellness & Safety 5 N/A

ResMed is a top performer compared to its peers and competitors Companies in this category manage its product and safety risks.
Employee Ownership, Satisfaction, Benefits & Pay 5 N/A

ResMed is a top performer among its peers for employee satisfaction and pay. A company’s score on this issue depends on its frequency and likelihood of labor disputes as well as its practices to keep and retain talent - such as compensation, family leave, employee health care and other benefits. Employers that are rated as good to work for consistently produce higher stock returns than their peers.
Workplace Health and Safety 3 N/A

ResMed is an average performer among its competitors on this issue. A company’s workplace health and safety is evaluated not only by the number of accidents and injuries in the workplace, but also by their safety policies, training procedures, and their investment in equipment that can reduce accidents.
Integrity of Corporate Governance 1 N/A

ResMed performs very poorly among its competitors on corporate governance. This score is determined by the company’s accounting practices, executive pay, board organization and ownership structure.
Ethical Practices — N/A

ResMed compared to its peers and competitors. A company’s rating on this issue is based on its history of controversies related to unethical corporate behavior, such as false claims about their products, price fixing, executive misconduct, insider trading or fraudulent practices.
Usage of Conflict Materials — N/A

ResMed among its competitors in this category. Certain products use raw materials that are commonly sourced from militias or other organizations that promote or engage in conflict in their region. To perform well in this category companies must provide adequate assurances that any of these metals used in their production are in fact from conflict-free sources.
Forced Labor — N/A

ResMed compared to its competitors on forced labor. A company’s score on this issue depends on its use of forced labor and on its work conditions for outsourced labor.
Diversity of Corporate Leadership 2 N/A

ResMed performs poorly based on its peers as well as companies in similar geographic regions. Companies are assessed on factors such as board diversity and senior management diversity. Companies performing well on this issue typically are more profitable than its peers, while companies with very poor scores typically have greater stock price volatility and lower returns on capital.

ResMed - Competitors and Related Companies

How ResMed stacks up to its peers in the Medical Specialties industry or with competing business segments.

ResMed

NYS:RMD

Medical Specialties

Market Cap

$14.58bn

LARGE cap

Share Price ↑

$102.00 (0.27%)

YTD Return ↓

-8.6274%

since start of 2019

P/E Ratio

—

RMD chart by TradingView

Source: FactSet financial data and analytics.

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data Privacy
Consumer Health
Employee Satisfaction
Workplace Safety
Corp Gov
Ethical Practices
Conflict Materials
Forced Labor
Gender Diversity

Legend

Loading…